OMNIPAQUE 300
GE HEALTHCARE CANADA INC
Quick answers
Is there a shortage of OMNIPAQUE 300 in Canada?
No. There is no current shortage of OMNIPAQUE 300 647MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
OMNIPAQUE 180 LIQ SAR 388MG/ML
SANOFI CANADA, INC.
OMNIPAQUE 350
GE HEALTHCARE CANADA INC
OMNIPAQUE 240 LIQ IV SAR 518MG/ML
SANOFI CANADA, INC.
OMNIPAQUE 300 LIQ IV SAR 647MG/ML
SANOFI CANADA, INC.
OMNIPAQUE 350 LIQ IV 755MG/ML
SANOFI CANADA, INC.
DIN
02172747
Strength
647MG
Dosage Form
Solution
Route
Intravascular Rectal Intra-Articular Subarachnoidal Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from GE HEALTHCARE CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.